The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: A collaborative evaluation
Abstract
BACKGROUND: The evaluation of organized mammographic service screening programs is a major challenge in public health. In particular, there is a need to evaluate the effect of the screening program on the mortality of breast carcinoma, uncontaminated in the screening epoch by mortality from 1) cases diagnosed in the prescreening period and 2) cases diagnosed among unscreened women (i.e., nonattenders) after the initiation of organized screening. METHODS: In the current study, the authors ascertained breast carcinoma deaths in the prescreening and screening epochs in 7 Swedish counties from tumors diagnosed in these epochs and in the age group 40–69 years in 6 counties and 50–69 years in 1 county. Data regarding deaths were obtained from the Uppsala Regional Oncologic Center in conjunction with the National Cause of Death Register. The total number of women in the eligible age range living in each county was obtained from the annual population data of Statistics Sweden. Detailed screening data were provided by the screening centers in the seven counties, including the number of invited, the number attended, and whether each individual breast carcinoma case was exposed (screen‐detected and interval cases combined) or unexposed (not‐invited or nonattenders) to mammographic screening. There were 2044 breast carcinoma deaths from 14,092 incident tumors diagnosed in the prescreening and screening epochs, and the total number of person‐years was 7.5 million. Data were analyzed using Poisson regression with corrections for self‐selection bias and lead‐time bias when appropriate. RESULTS: The mortality reduction for breast carcinoma in all 7 counties combined for women actually exposed to screening compared with the prescreening period was 44% (relative risk [RR] = 0.56; 95% confidence interval [95% CI], 0.50–0.62). When all incident tumors were considered, both those exposed and those unexposed to screening combined, counties with > 10 years of screening were found to demonstrate a significant 32% mortality reduction (RR = 0.68; 95% CI, 0.60–0.77) and counties with ≤ 10 years of screening showed a significant 18% reduction in breast carcinoma mortality (RR = 0.82; 95% CI, 0.72–0.94) for the screening epoch compared with the prescreening epoch. Within the screening epoch, after adjustment for self‐selection bias, a 39% mortality reduction (RR = 0.61; 95%CI, 0.55–0.68) was observed in association with invitation to screening. CONCLUSIONS: Organized service screening in 7 Swedish counties, covering approximately 33% of the population of Sweden, resulted in a 40–45% reduction in breast carcinoma mortality among women actually screened. The policy of offering screening is associated with a mortality reduction in breast carcinoma of 30% in the invited population, exposed and unexposed combined. The results of the current study indicate that the majority of the breast carcinoma mortality reduction is indeed due to the screening. [See editorial on pages 451–7, this issue.] Cancer 2002;95:458–69. © 2002 American Cancer Society. DOI 10.1002/cncr.10765
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness
Tengs, T. O., Adams, M. E., Pliskin, J. S., Safran, D. G., Siegel, J. E., Weinstein, M. C., & Graham, J. D. (1995) · Risk Analysis · doi:10.1111/j.1539-6924.1995.tb00330.x · Cited by 1,321
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Breast cancer screening with mammography: overview of Swedish randomised trials
Nyström, L., Wall, S., Rutqvist, L. E., Lindgren, A., Lindqvist, M., Rydén, S., Andersson, J., Bjurstam, N., Fagerberg, G., Frisell, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91067-v · Cited by 968
Self-citationIs screening for breast cancer with mammography justifiable?
Gøtzsche, P. C., & Olsen, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06065-1 · Cited by 853
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Tab�r, L., Vitak, B., Chen, H.-H. T., Yen, M.-F., Duffy, S. W., & Smith, R. A. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1724::aid-cncr1190>3.0.co;2-v · Cited by 560
Self-citationTHE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Self-citationAll-Cause Mortality in Randomized Trials of Cancer Screening
Black, W. C. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.167 · Cited by 390
Cited by
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Self-citationTabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
Self-citationDeep Neural Networks Improve Radiologists’ Performance in Breast Cancer Screening
Wu, N., Phang, J., Park, J., Shen, Y., Huang, Z., Zorin, M., Jastrzebski, S., Fevry, T., Katsnelson, J., Kim, E., et al. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2945514 · Cited by 689
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Metadata
- Authors
- Duffy, S. W., Tabár, L., Chen, H., Holmqvist, M., Yen, M., Abdsalah, S., Epstein, B., Frodis, E., Ljungberg, E., Hedborg‐Melander, C., Sundbom, A., Tholin, M., Wiege, M., Åkerlund, A., Wu, H., Tung, T., Chiu, Y., Chiu, C., Huang, C., Smith, R. A., Rosén, M., Stenbeck, M., & Holmberg, L.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-07-23
- Volume
- 95
- Issue
- 3
- Pages
- 458-469
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1508572307
- Cited by
- 429
- References
- 19
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: A collaborative evaluation. https://app.cochat.ai/papers/10.1002/cncr.10765
- The paper
- Duffy, S. W., Tabár, L., Chen, H., Holmqvist, M., Yen, M., Abdsalah, S., Epstein, B., Frodis, E., Ljungberg, E., Hedborg‐Melander, C., Sundbom, A., Tholin, M., Wiege, M., Åkerlund, A., Wu, H., Tung, T., Chiu, Y., Chiu, C., Huang, C., . . . Holmberg, L. (2002). The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: A collaborative evaluation. Cancer. https://doi.org/10.1002/cncr.10765
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.